Systemic bevacizumab (Bev) for leptomeningeal disease (LMD) from non-small cell lung cancer Meeting Abstract
| Authors: | Carlo, M.; Omuro, A.; Grommes, C.; Kris, M.; Nolan, C.; Pentsova, E.; Pietanza, M.; Kaley, T. |
| Abstract Title: | Systemic bevacizumab (Bev) for leptomeningeal disease (LMD) from non-small cell lung cancer |
| Meeting Title: | 4th Quadrennial Meeting of the World Federation of Neuro-Oncology (WFNO)/18th Annual Meeting of the Society for Neuro-Oncology (SNO) |
| Journal Title: | Neuro-Oncology |
| Volume: | 15 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2013 Nov 21-24 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 1522-8517 |
| Publisher: | Oxford University Press |
| Date Published: | 2013-11-01 |
| Start Page: | iii104 |
| Language: | English |
| ACCESSION: | WOS:000327456200418 |
| PROVIDER: | wos |
| DOI: | 10.1093/neuonc/not182 |
| PMCID: | PMC3823897 |
| Notes: | Meeting Abstract: NO-026 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
